The LINCE Project: A Pathway for Diagnosing NCL2 Disease
IntroductionNeuronal Ceroid Lipofuscinosis (NCL) comprises a clinically and genetically heterogeneous group of 13 neurodegenerative lysosomal storage disorders. Neuronal Ceroid lipofuscinosis type 2 disease (NCL2), caused by the deficient lysosomal enzyme tripeptidyl peptidase 1 (TPP1), is the only...
Guardado en:
Autores principales: | Daniel Rodrigues (Autor), Maria José de Castro (Autor), Pablo Crujeiras (Autor), Anna Duat-Rodriguez (Autor), Ana Victoria Marco (Autor), Mireia del Toro (Autor), María L. Couce (Autor), Cristóbal Colón (Autor) |
---|---|
Formato: | Libro |
Publicado: |
Frontiers Media S.A.,
2022-03-01T00:00:00Z.
|
Materias: | |
Acceso en línea: | Connect to this object online. |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens
por: Hongfei Pi, et al.
Publicado: (2022) -
Reply letter to "safety of SARS-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance"
por: Rebeca Saborido-Fiaño, et al.
Publicado: (2021) -
Letter to the editor concerning the article 'Safety of vaccines administration in hereditary fructose intolerance'
por: Rebeca Saborido-Fiaño, et al.
Publicado: (2021) -
Editorial: Risk and preventive factors in necrotizing enterocolitis and its complications in premature infants
por: María L. Couce
Publicado: (2022) -
Fifty years of neonatal screening for congenital diseases in Spain
por: María-Luz Couce
Publicado: (2019)